New Data Published in Nature Medicine from Joslin Diabetes Center Demonstrates the Importance of Interrogating Human Biology - Seite 2
"This paper represents a novel method for studying metabolic diseases by introducing an environmental element, in this case cold exposure, to activate brown fat and potentially advance innovative treatments in diabetes," said Niven R. Narain, BERG Co-Founder, President and Chief Executive Officer of BERG. "We are very pleased to be a part of this important study with Joslin Diabetes Center and are encouraged by these new findings. Through our Interrogative Biology® platform, we hope to able to identify important biomarkers for future studies that can speed the delivery of meaningful treatments to patients."
About BERG
BERG is a clinical-stage company disrupting and re-defining the approach to drug discovery, research and development through its Interrogative Biology® platform. Its platform identifies
therapies and biomarkers by applying algorithm- and probability-based artificial intelligence to analyze large numbers of patients' genotypic, phenotypic and other characteristics. BERG's
platform operates at the intersection of biology, technology and artificial intelligence analytics and integrates many data characteristics regarding patients' lifestyles, demographics and
biology. BERG believes this allows the company to better understand patients' disease profiles and consequently to identify and reveal molecular signatures to guide and accelerate product
candidate selection and development. By identifying biomarkers and patient characteristics that are unique to the disease state, BERG is able to identify novel therapeutic product candidates and
develop companion diagnostics to enhance specificity in its drug development process. BERG has leveraged its Interrogative Biology® platform to develop a robust pipeline of therapeutic product
candidates and diagnostics in cancer, diabetes and neurology.
For additional information, please visit www.BERGhealth.com.
Lesen Sie auch
CONTACT:
Lisa Rivero
Ogilvy
+1.617.761.6746